Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for the Pharma Savvy

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jun 12, 2024 11:03pm

153 Views

Post# 36086346

RE:RE:RE:RE:RE:Question for the Pharma Savvy

Yes, BK. What you said. As a buy in for one indication. That's all they have now. Future valuation would be based on negotiated potential (based on indications that need to be funded for trials first). End of my speculations. Back to waiting and watching.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market